{"id":24668,"date":"2016-02-25T12:26:24","date_gmt":"2016-02-25T11:26:24","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=24668"},"modified":"2016-02-26T12:41:13","modified_gmt":"2016-02-26T11:41:13","slug":"m5s-trasparenza-medici-aziende","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/m5s-trasparenza-medici-aziende\/","title":{"rendered":"M5S medical company transparency"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" src=\"http:\/\/www.interno.gov.it\/sites\/default\/files\/styles\/top_pagina\/public\/field\/image\/anac_anticorruzione.jpg?itok=uq1SdgKW\" alt=\"\" width=\"431\" height=\"195\" \/>M5S against Farmindustria on the transparency of the relationship between doctors and companies. \u201cFrankly, we don&#039;t agree with the words pronounced by the president of Farmindustria Massimo Scarabozzi when, with regard to the new code of conduct adopted by Efpia, he speaks of a tool that is also useful for disavowing the &#039;prejudices&#039; on relations between pharmaceutical companies and white coats.<\/p>\n<p>Unfortunately, the opaque nature of these reports does not arise from urban legends, but is documented by facts for which we have asked the<strong>Anac<\/strong>\u201c. This was stated by the M5S deputies in the Social Affairs Commission, commenting on the words of the president of Farminusteria on the new code of conduct approved by the European Federation of Pharmaceutical Industries and Associations.<\/p>\n<p>The code provides for the publication by 30 June of all payments made to doctors by the drug industries. &quot;We asked Doctor Cantone, president of Anac - explain the pentastellati deputies - for an opinion, with respect to which we are awaiting an answer, on how the &#039;Medicine Agency fulfills the tasks relating to the legal obligations envisaged for&#039; conferences, congresses and other drug-related meetings&#039;<\/p>\n<p><a href=\"http:\/\/streamer.adnkronos.com\/Salute\/Newsletter\/data\/Pk3416.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">February 25, 2016 \u2013 Pharma<em>Kronos<\/em><\/span><\/a><\/p>\n<p>Related news:\u00a0<a href=\"http:\/\/www.beppegrillo.it\/movimento\/parlamento\/2016\/02\/per-farmindustria-solo-pregiudizi-su-rapporti-aziende-e-camici-bianchi-i-fatti-dicono-il-contrario.html\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">For Farmindustria only prejudices on company relations and &quot;white coats&quot;? The facts say the opposite<\/span><\/a><\/p>\n<p><a href=\"http:\/\/www.quotidianosanita.it\/scienza-e-farmaci\/articolo.php?articolo_id=36786\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Pharmaceutical companies and doctors. From 30 June the economic contributions paid will be &#039;public&#039;. Farmindustria: \u201cIn the name of transparency. Implemented our European code&quot;<\/span><\/a><\/p>\n<p><a href=\"http:\/\/www.quotidianosanita.it\/scienza-e-farmaci\/articolo.php?approfondimento_id=7295\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\"><strong>M5s: <\/strong>\u201cNow clarity on the whole process\u201d<\/span><\/a><\/p>\n<p class=\"asset-name entry-title\"><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"http:\/\/www.beppegrillo.it\/movimento\/parlamento\/affarisociali\/2016\/02\/epatite-c-abbiamo-costretto-laifa-al-dietrofront-sul-sistema-di-rimborso-alle-regioni.html\" target=\"_blank\" rel=\"bookmark noopener\">Hepatitis C: we forced AIFA to turn around on the reimbursement system for the Regions<\/a><\/span><\/p>\n<p class=\"entry-title\"><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"http:\/\/medicalive.it\/vaccini-aifa-conciliare-prezzo-sostenibile-e-profitti\/\" target=\"_blank\" rel=\"noopener\">Vaccines: Aifa, reconciling sustainable price and profits<\/a><\/span><\/p>\n<p><a href=\"http:\/\/transparency.efpia.eu\/countries\/download\/14\/document\/code-2-luglio-2014.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">CODE OF CONDUCT FARMINDUSTRIA<\/span><\/a><\/p>\n<p><a href=\"http:\/\/www.farmindustria.it\/index.php?option=com_jdownloads&amp;Itemid=0&amp;view=finish&amp;cid=115477&amp;catid=39\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Farmindustria Code of Conduct<\/span><\/a><\/p>\n<p><a href=\"http:\/\/transparency.efpia.eu\/the-efpia-code-2\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">The EFPIA Code of Conduct<\/span><\/a><\/p>\n<p><a href=\"http:\/\/www.quotidianosanita.it\/allegati\/allegato5469986.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">EFPIA Code of Ethics<\/span><\/a><\/p>\n<p><a href=\"http:\/\/www.anticorruzione.it\/portal\/public\/classic\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">ANaC<\/span><\/a><\/p>\n<p><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"http:\/\/transparency.efpia.eu\/countries\/14\/16\/Italy\" target=\"_blank\" rel=\"noopener\">EFPIA Codes of Conduct<\/a><\/span><\/p>\n<div class=\"mcf_countries\">\n<h2><span style=\"color: #ff0000;\">EFPIA Italy<\/span><\/h2>\n<div class=\"right-box\">\n<div class=\"side-box\">\n<div class=\"green-gradient side-box-heading\">Download<\/div>\n<div class=\"grey-gradient side-box-content\">\n<ul class=\"reset-list related-documents\">\n<li>\n<div class=\"download\"><a href=\"http:\/\/transparency.efpia.eu\/countries\/download\/14\/document\/code-2-luglio-2014.pdf\" target=\"_blank\" rel=\"noopener\">Code of Conduct_Italy<span class=\"extension\">(PDF)<\/span><\/a><\/div>\n<div class=\"size\">118.92 kB<\/div>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"summary\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright\" src=\"http:\/\/www.fedaiisf.it\/wp-content\/uploads\/2014\/12\/efpia-890x395_c.jpg\" alt=\"\" width=\"367\" height=\"163\" \/>In order to comply with the statutory provisions and the rules established by the European codes of conduct and international federations of the pharmaceutical industry (EFPIA and IFPMA), Farmindustria has elaborated a professional code of conduct in the form of a voluntary agreement entered into by the pharmaceutical companies belonging at Farmindustria. The Code aims to regulate relations not only between companies, but also their relations with the scientific and health sectors.<\/p>\n<div class=\"details\">\n<p>All companies associated with Farmindustria must accept and comply with the provisions of the Code of Professional Conduct. The following are excluded from the scope of application of this Code:<\/p>\n<ul class=\"content-list\">\n<li>Activities intended to disseminate non-promotional information, general information about the company (such as direct investor information or the press), including financial data and descriptions of research and development, provided that healthcare professionals are present in non-prevalent numbers .<\/li>\n<li>institutional events organized by pharmaceutical companies on issues that go beyond promotional information, which are of interest to a variety of individuals from all potentially affected areas, which are held in the right places and where healthcare professionals are present in quantity not prevalent.<\/li>\n<\/ul>\n<p>The Code represents the sector&#039;s commitment not only to comply with the specific laws in force, but also to operate on the basis of transparent rules of conduct which regulate the various circumstances in which the company&#039;s activities take place.<\/p>\n<p>The regulations that form the subject of the code of professional conduct have been drawn up in the general interest and to safeguard the prestige and honor of the pharmaceutical industry towards the state, the public opinion, the medical profession and health professionals in general .<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>M5S contro Farmindustria sulla trasparenza del rapporto tra medici e aziende. &#8220;Francamente non condividiamo le parole pronunciate dal presidente di Farmindustria Massimo Scarabozzi quando, a proposito del nuovo codice di condotta adottato dalla Efpia, parla di uno strumento tra l&#8217;altro utile a sconfessare i &#8216;pregiudizi&#8217; sulle relazioni tra aziende farmaceutiche e camici bianchi. Purtroppo la &hellip;<\/p>","protected":false},"author":4,"featured_media":4712,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[50,22],"class_list":["post-24668","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-farmindustria","tag-truffa-farmaci"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/24668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=24668"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/24668\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/4712"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=24668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=24668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=24668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}